Efficacy and safety of Pien Tze Huang capsules in patients with herpes zoster: A multicenter, randomized, double-blinded, and placebo-controlled trial

医学 安慰剂 随机对照试验 内科学 双盲 多中心研究 双盲 替代医学 病理
作者
Wenfeng Wu,Dingquan Yang,Daoshun Sui,Minghua Zhu,Guangpu Luo,Zhonghui Yang,Yongfeng Wang,Hong Luo,Ling Li,Zexin Zhang,Yanmei Wu,Guoming Feng,Hongyi Li
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:127: 155453-155453 被引量:7
标识
DOI:10.1016/j.phymed.2024.155453
摘要

BACKGROUND: Herpes zoster (HZ) is a common medical condition accompanied by several distressing symptoms, including acute pain. Pien Tze Huang (PZH) is a well-known traditional Chinese medicine (TCM) with numerous pharmacological effects, including antiviral properties, neuroprotection, and immunity regulation. PURPOSE: To investigate the efficacy and safety of PZH capsules in patients with HZ. STUDY DESIGN: A multicenter, double-blinded, randomized, and placebo-controlled trial from 8 hospitals in 5 cities of China. METHODS: Eligible participants were randomly assigned to the PZH capsule and placebo group at a 1:1 ratio. Treatment was conducted for 14 days with a window period of no more than 2 days. For the first 7 days, participants received antiviral drugs combined with PZH capsules (0.6 g/time, 3 times a day) or placebos. For the remaining 7 days, they were only treated with PZH capsules (0.6 g/time, 3 times a day) or placebos. RESULTS: We included 222 patients in the full analysis set (FAS), and 187 patients in the per protocol set (PPS). The change of numeric rating scale pain scores from baseline to the seventh day (±1 day) after treatment in the PZH capsule group was statistically superior to the placebo group (FAS: 2.33 vs. 1.71, 97.5%CI: 0.03 ∼ 1.19; PPS: 2.29 vs. 1.51, 97.5%CI: 0.18 ∼ 1.38). In the PPS, there was a significant difference in the time (days) of pain relief between the placebo group and the PZH capsule group (Mean (SD): 5.71 (3.76) vs. 4.69 (3.57), p = 0.046). On the seventh day (±1 day) after treatment, the level of CD8+ cells in the PZH capsule group were higher than those of the placebo group (FAS: Mean (SD): 24.08 (6.81) vs. 21.93 (8.19), p = 0.007; PPS: Mean (SD): 24.26 (6.93) vs. 22.15 (8.51), p = 0.012). The level of cytotoxic lymphocyte cells found similar results on the seventh day (±1 day) (FAS: Mean (SD): 12.17 (4.65) vs. 10.55 (4.15), p = 0.018; PPS: Mean (SD): 12.25 (4.65) vs. 10.11 (3.93), p = 0.002). No serious adverse events were noted and PZH capsules were well tolerated. CONCLUSION: PZH capsules confer therapeutic effects on HZ with the TCM symptom of stagnated heat of liver channel by substantially reducing the pain intensity, shortening the time of pain relief as well as regulating the immune function. On the basis of the efficacy and safety profiles, PZH capsules may be a promising complementary therapy for the treatment of HZ.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wjw201407完成签到,获得积分20
1秒前
慕青的应助被科研通管家采纳,获得10
1秒前
科研通AI2S的应助被科研通管家采纳,获得10
1秒前
Jasper的应助被科研通管家采纳,获得10
1秒前
香蕉觅云的应助被科研通管家采纳,获得10
1秒前
田様的应助被科研通管家采纳,获得10
1秒前
烟花的应助被科研通管家采纳,获得10
2秒前
Hello的应助被科研通管家采纳,获得10
2秒前
乐空思的应助被科研通管家采纳,获得100
2秒前
GPTea的应助被科研通管家采纳,获得20
2秒前
华仔的应助被科研通管家采纳,获得10
2秒前
小二郎的应助被科研通管家采纳,获得10
2秒前
2秒前
NexusExplorer的应助被科研通管家采纳,获得10
3秒前
lsong完成签到,获得积分10
3秒前
3秒前
Akim的应助被金木水采纳,获得10
3秒前
阔达雁的应助被科研通管家采纳,获得30
3秒前
3秒前
3秒前
molihuakai的应助被科研通管家采纳,获得10
3秒前
laonaiyi发布了新的文献求助30
3秒前
3秒前
Xu发布了新的文献求助10
4秒前
6秒前
顾矜的应助被XXXX采纳,获得10
6秒前
wg发布了新的文献求助10
7秒前
黑兔子发布了新的文献求助10
7秒前
7秒前
7秒前
脑洞疼的应助被kk采纳,获得10
8秒前
清秀蹇完成签到,获得积分10
8秒前
思源的应助被zcnsdtc1991采纳,获得10
8秒前
小白完成签到,获得积分10
8秒前
8秒前
10秒前
rbybxxaq完成签到,获得积分10
11秒前
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165135
求助须知:如何正确求助?哪些是违规求助? 9558801
关于积分的说明 21747483
捐赠科研通 7755702
什么是DOI,文献DOI怎么找? 3428797
关于科研通互助平台的介绍 2553162
邀请新用户注册赠送积分活动 2473402